Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 4/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | FYN | P06241 | 5/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16724634 | 0.90 | HSP90AA1 (0.36) | HSP90AA1HSP90AB1FYN | |
| SCHEMBL16724619 | 0.88 | HSP90AA1 (0.36) | HSP90AA1HSP90AB1FYN | |
| SCHEMBL16714465 | 0.88 | HSP90AA1 (0.38) | HSP90AA1HSP90AB1PTGS2AHR | |
| SCHEMBL16724617 | 0.88 | HSP90AA1 (0.41) | HSP90AA1HSP90AB1FYN | |
| SCHEMBL16724646 | 0.87 | APP (0.38) | HSP90AA1HSP90AB1FYN | |
| SCHEMBL16724655 | 0.86 | HSP90AA1 (0.38) | HSP90AA1HSP90AB1FYN | |
| SCHEMBL16724623 | 0.86 | HSP90AA1 (0.35) | HSP90AA1HSP90AB1FYNAHR | |
| SCHEMBL16724638 | 0.86 | HSP90AA1 (0.35) | HSP90AA1HSP90AB1FYN | |
| SCHEMBL16724610 | 0.86 | APP (0.46) | AHR | |
| SCHEMBL16724656 | 0.85 | HSP90AA1 (0.34) | HSP90AA1HSP90AB1ROCK2PTGS2AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187467-B2 | 2-phenyl benzothiazole linked imidazole compounds as potential anticancer agents and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-11-17 | — | — | US | disclosed |
| US-20150141657-A1 | 2-PHENYL BENZOTHIAZOLE LINKED IMIDAZOLE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141657-A1 | 2-PHENYL BENZOTHIAZOLE LINKED IMIDAZOLE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF | NFE2L2, TPT1, CCNT1 | HSP90AA1 206/4885HSP90AB1 115/4885ROCK2 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.